Lynch Biologics is a biotechnology startup headquartered in the United States that focuses on providing safe and effective therapies. The company's slogan, "Providing safe and effective therapies including GEM 21S to help patients heal faster, safer, and more completely," reflects its commitment to regenerative science for healing. Founded in 2015, Lynch Biologics offers treatment options for patients with various wound care challenges, from dental defects to skin wounds, using bioactive proteins. The company's leadership team is passionate about improving lives physically, emotionally, and spiritually, and they emphasize their technology's potential to change lives and their products' healing capabilities. As of now, there is no public information available regarding their last investment or the investors involved.
There is no investment information
No recent news or press coverage available for Lynch Biologics.